1,346
Views
1
CrossRef citations to date
0
Altmetric
Article

Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical Resection

, , , , , , & show all
Pages 3533-3545 | Received 19 Jul 2021, Accepted 13 May 2022, Published online: 01 Jun 2022

References

  • Chen W. Cancer statistics: updated cancer burden in China. Chin J Cancer Res. 2015;27(1):1. doi: 10.3978/j.issn.1000-9604.2015.02.07.
  • Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94. doi: 10.4065/83.5.584.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49. doi: 10.3322/CA.2007.0010.
  • Lüchtenborg M, Riaz SP, Lim E, Page R, Baldwin DR, Jakobsen E, Vedsted P, Lind M, Peake MD, Mellemgaard A, et al. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009. Thorax. 2014;69(3):269–73. doi: 10.1136/thoraxjnl-2013-203884.
  • Duan X, Cui Y, Li H, Shi G, Wu B, Liu M, Chang D, Wang T, Kong Y. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer. Indian J Cancer. 2015;52(7):158–63. doi:10.4103/0019-509X.186564
  • Li S, Cao L, Wang X, Wang F, Wang L, Jiang R. Neuron-specific enolase is an independent prognostic factor in resected lung adenocarcinoma patients with anaplastic lymphoma kinase gene rearrangements. Med Sci Monit. 2019;25:675–90. doi: 10.12659/MSM.913054.
  • Maeda R, Suda T, Hachimaru A, Tochii D, Tochii S, Takagi Y. Clinical significance of preoperative carcinoembryonic antigen level in patients with clinical stage IA non-small cell lung cancer. J Thorac Dis. 2017;9(1):176–86. doi: 10.21037/jtd.2017.01.30.
  • Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol. 2015;12(11):676–82. doi: 10.1038/nrclinonc.2015.132.
  • Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp. 2012;27:707–14. doi:10.3305/nh/2012.27.3.5567
  • McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–6. doi: 10.1097/MCO.0b013e32832a7902.
  • Zhang Y, Zhu JY, Zhou LN, Tang M, Chen MB, Tao M. Predicting the prognosis of gastric cancer by albumin/globulin ratio and the prognostic nutritional index. Nutr Cancer. 2020;72(4):635–44. doi: 10.1080/01635581.2019.1651347.
  • Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S, Polterauer S, Harter P, Grimm C, et al. Pre-operative serum albumin is associated with postoperative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015;138(3):560–5. doi:10.1016/j.ygyno.2015.07.005
  • Chiang JM, Chang CJ, Jiang SF, Yeh CY, You JF, Hsieh PS, Huang HY. Pre-operative serum albumin level substantially predicts post-operative morbidity and mortality among patients with colorectal cancer who undergo elective colectomy. Eur J Cancer Care. 2017;26(2):e12403. Epub 2015 Nov 3. doi:10.1111/ecc.12403
  • Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the c-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23(3):900–7. doi:10.1245/s10434-015-4948-7
  • Duran AO, Inanc M, Karaca H, Dogan I, Berk V, Bozkurt O, Ozaslan E, Ucar M, Eroglu C, Ozkan M, et al. Albumin–globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients. Asian Pac J Cancer Prev. 2014;15(15):6449–53. doi:10.7314/APJCP.2014.15.15.6449
  • Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D. Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection. OTT. 2017;ume 10:2155–62. doi:10.2147/OTT.S99282
  • Feng L, Gu S, Wang P, Chen H, Chen Z, Meng Z, Liu L. Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer. Cancer Med. 2018;7(12):5943–51. doi: 10.1002/cam4.1848.
  • Shi H, Wang XH, Gu JW, Guo GL. Development and validation of nomograms for predicting the prognosis of triple-negative breast cancer patients based on 379 Chinese patients. Cancer Manag Res. 2019;11:10827–39. doi: 10.2147/CMAR.S234926.
  • Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z. Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma. Onco Targets Ther. 2017;10:1441–9. doi: 10.2147/OTT.S124161.
  • Li Y, Wu H, Xing C, Hu X, Zhang F, Peng Y, Li Z, Lu T. Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood. J Cancer. 2020;11(13):3834–45. doi:10.7150/jca.42409
  • Lin J-X, Lin J-P, Xie J-W, Wang J-B, Lu J, Chen Q-Y, Cao L-L, Lin M, Tu R, Zheng C-H, et al. Preoperative hematocrit (HCT) is a novel and simple predictive marker for gastric cancer patients who underwent radical gastrectomy. Ann Surg Oncol. 2019;26(12):4027–36. doi: 10.1245/s10434-019-07582-7.
  • Tu J, Wen L, Huo Z, Wang B, Wang Y, Liao H, Liu W, Zhong X, Kong J, Wang M, et al. Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma. BMC Cancer. 2018;18(1):428. doi: 10.1186/s12885-018-4279-8.
  • Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF. High mean corpuscular volume predicts poor outcome for patients with gastroesophageal adenocarcinoma. Ann Surg Oncol. 2019;26(4):976–85. doi: 10.1245/s10434-019-07186-1.
  • Kiuchi J, Komatsu S, Kosuga T, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Ichikawa D, Otsuji E, et al. Long-term postoperative nutritional status affects prognosis even after infectious complications in gastric cancer. Anticancer Res. 2018;38(5):3133–8. doi: 10.21873/anticanres.12575.
  • Deng Y, Ma J, Tang D, Zhang Q. Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients. Clin Transl Oncol. 2021;23(7):1481–90. doi: 10.1007/s12094-020-02547-9.
  • Dru RC, Curtis NJ, Court EL, Spencer C, El Falaha S, Dennison G, Dalton R, Allison A, Ockrim J, Francis NK, et al. Impact of anaemia at discharge following colorectal cancer surgery. Int J Colorectal Dis. 2020;35(9):1769–76. doi:10.1007/s00384-020-03611-0
  • Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10(21):7252–9.
  • Lowczak A, Kolasinska-Cwikla A, Ćwikła JB, Osowiecka K, Palucki J, Rzepko R, Glinka L, Doboszyńska A. Outcomes of patients with clinical stage I–IIIA large-cell neuroendocrine lung cancer treated with resection. JCM. 2020;9(5):1370. doi:10.3390/jcm9051370
  • Ost D, Goldberg J, Rolnitzky L, Rom WN. Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med. 2008;177(5):516–23. doi:10.1164/rccm.200706-815OC
  • Liu L, Shi M, Wang Z, Lu H, Li C, Tao Y, Chen X, Zhao J. A molecular and staging model predicts survival in patients with resected non-small cell lung cancer. BMC Cancer. 2018;18(1):966. doi: 10.1186/s12885-018-4881-9.
  • Mecklenburg I, Sienel W, Schmid S, Passlick B, Kufer P. A threshold of systemic MAGE-A gene expression predicting survival in resected non-small cell lung cancer. Clin Cancer Res. 2017;23(5):1213–9. doi:10.1158/1078-0432.CCR-16-0557
  • Schneider MA, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, Herth FJF, Dienemann H, Mueller NS, Theis F, et al. AURKA, DLGAP5, TPX2, KIF11 and CKAP5: five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients. Int J Oncol. 2017;50(2):365–72. doi: 10.3892/ijo.2017.3834.
  • Li T, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol. 2013;31(8):1039–49. doi: 10.1200/JCO.2012.45.3753.
  • Jagoe RT, Goodship TH, Gibson GJ. Nutritional status of patients undergoing lung cancer operations. Ann Thorac Surg. 2001;71(3):929–35. doi: 10.1016/s0003-4975(00)02005-1.
  • Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396–407. doi: 10.1016/j.jhep.2014.04.012.
  • Pfensig C, Dominik A, Borufka L, Hinz M, Stange J, Eggert M. A new application for albumin dialysis in extracorporeal organ support: characterization of a putative interaction between human albumin and proinflammatory cytokines IL-6 and TNFα. Artif Organs. 2016;40(4):397–402. doi: 10.1111/aor.12557.
  • Mao M-J, Wei X-L, Sheng H, Wang X-P, Li X-H, Liu Y-J, Xing S, Huang Q, Dai S-Q, Liu W-L, et al. Clinical significance of preoperative albumin and globulin ratio in patients with gastric cancer undergoing treatment. Biomed Res Int. 2017;2017:3083267. doi: 10.1155/2017/3083267.
  • Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol. 1997;100(2):151–7. doi: 10.1016/s0091-6749(97)70217-3.
  • Jiang Z, Li Y, Han G, Zhang J, Li Z, Wang D, Liu Y. Association of serum albumin level with clinicopathologic features and prognosis in colon cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19:80–3.
  • Borsetto D, Polesel J, Tirelli G, Menegaldo A, Baggio V, Gava A, Nankivell P, Pracy P, Fussey J, Boscolo-Rizzo P, et al. Pretreatment high MCV as adverse prognostic marker in nonanemic patients with head and neck cancer. Laryngoscope. 2021;131(3):E836–45. doi: 10.1002/lary.28882.
  • Zheng YZ, Dai SQ, Li W, Cao X, Li Y, Zhang LJ, Fu JH, Wang JY. Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma. WJG. 2013;19(18):2811–7. doi:10.3748/wjg.v19.i18.2811
  • Habler OP, Messmer KF. Tissue perfusion and oxygenation with blood substitutes. Adv Drug Deliv Rev. 2000;40(3):171–84. doi: 10.1016/s0169-409x(99)00048-4.
  • Harrison L, Blackwell K. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist. 2004;9(S5):31–40. doi:10.1634/theoncologist.9-90005-31
  • Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9(S5):10–7. doi:10.1634/theoncologist.9-90005-10
  • Espinosa E, Feliu J, Zamora P, González Barón M, Sánchez JJ, Ordón ez A, Espinosa J. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 1995;12(1-2):67–76. doi: 10.1016/0169-5002(95)00407-r.
  • Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF, et al. The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction. Oncotarget. 2018;9(6):6968–76. doi:10.18632/oncotarget.24087
  • Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2):381–9. doi: 10.1245/s10434-006-9093-x.
  • Nagai H, Yuasa N, Takeuchi E, Miyake H, Yoshioka Y, Miyata K. The mean corpuscular volume as a prognostic factor for colorectal cancer. Surg Today. 2018;48(2):186–94. doi:10.1007/s00595-017-1575-x
  • Yoon HJ, Kim K, Nam YS, Yun JM, Park M. Mean corpuscular volume levels and all-cause and liver cancer mortality. Clin Chem Lab Med. 2016;54:1247–57. doi:10.1515/cclm-2015-0786
  • Zubieta-Calleja GR, Zubieta-DeUrioste NA. Extended longevity at high altitude: benefits of exposure to chronic hypoxia. BLDE Univ J Health Sci. 2017;2(2):80–90. doi:10.4103/bjhs.bjhs_7_17
  • León-Velarde F, Gamboa A, Chuquiza JA, Esteba WA, Rivera-Chira M, Monge CC. Hematological parameters in high altitude residents living at 4,355, 4,660, and 5,500 meters above sea level. High Alt Med Biol. 2000;1(2):97–104. doi:10.1089/15270290050074233
  • Zubieta-Calleja G, Zubieta-DeUrioste N. The oxygen transport triad in high-altitude pulmonary edema: a perspective from the high Andes. IJERPH. 2021;18(14):7619. doi:10.3390/ijerph18147619